Nigel Stallard
Overview
Explore the profile of Nigel Stallard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
149
Citations
2299
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Platt R, Stallard N, McShane L, Van Calster B, Albert P
Stat Med
. 2025 Jan;
44(1-2):e10273.
PMID: 39775600
No abstract available.
2.
Basu J, Parsons N, Friede T, Stallard N
Stat Methods Med Res
. 2024 Oct;
33(11-12):2131-2143.
PMID: 39474813
Cancellation or delay of non-essential medical interventions, limitation of face-to-face assessments or outpatient attendance due to lockdown restrictions, illness or fear of hospital or healthcare centre visits, and halting of...
3.
Stallard N
Stat Methods Med Res
. 2024 Sep;
33(11-12):1967-1978.
PMID: 39319446
There is a growing interest in clinical trials that investigate how patients may respond differently to an experimental treatment depending on the basis of some biomarker measured on a continuous...
4.
Pal S, Chataway J, Swingler R, Macleod M, Carragher N, Hardingham G, et al.
Lancet Neurol
. 2024 Sep;
23(11):1097-1107.
PMID: 39307154
Background: Motor neuron disease represents a group of progressive and incurable diseases that are characterised by selective loss of motor neurons, resulting in an urgent need for rapid identification of...
5.
John N, Li Y, De Angelis F, Stutters J, Carrasco F, Eshaghi A, et al.
BMJ Neurol Open
. 2024 Sep;
6(2):e000670.
PMID: 39262426
Background: The brain reserve hypothesis posits that larger maximal lifetime brain growth (MLBG) may confer protection against physical disability in multiple sclerosis (MS). Larger MLBG as a proxy for brain...
6.
Yarahmadi A, Dodd L, Jaki T, Horby P, Stallard N
Stat Med
. 2024 Aug;
43(24):4667-4683.
PMID: 39165101
Motivated by the experience of COVID-19 trials, we consider clinical trials in the setting of an emerging disease in which the uncertainty of natural disease course and potential treatment effects...
7.
Saravanan P, Deepa M, Ahmed Z, Ram U, Surapaneni T, Kallur S, et al.
Lancet Diabetes Endocrinol
. 2024 Jun;
12(8):535-544.
PMID: 38936371
Background: More than 90% of gestational diabetes cases are estimated to occur in low-income and middle-income countries (LMICs). Most current guidelines recommend an oral glucose tolerance test (OGTT) at 24-28...
8.
Parsons N, Basu J, Stallard N
BMC Med Res Methodol
. 2024 Feb;
24(1):42.
PMID: 38365621
Background: Group sequential designs are one of the most widely used methodologies for adaptive design in randomized clinical trials. In settings where early outcomes are available, they offer large gains...
9.
Freeman K, Jenkinson D, Clements K, Wallis M, Pinder S, Provenzano E, et al.
BMJ
. 2024 Feb;
384:e077039.
PMID: 38302129
Objective: To explore how the number and type of breast cancers developed after screen detected atypia compare with the anticipated 11.3 cancers detected per 1000 women screened within one three...
10.
Freeman K, Mansbridge A, Stobart H, Clements K, Wallis M, Pinder S, et al.
Br J Radiol
. 2024 Jan;
97(1154):324-330.
PMID: 38265306
Evidence-based clinical guidelines are essential to maximize patient benefit and to reduce clinical uncertainty and inconsistency in clinical practice. Gaps in the evidence base can be addressed by data acquired...